Program
Sunday, April 30, 2017
7:30 - 8:30
Registration and Breakfast
Speaker
8:30 - 8:45
Welcome - opening ceremony
8:45 -10:30
Setting the Scene: Basic Understanding of Keloid Disorder
Epidemiological and Clinical Aspects of Keloids in Africa.
Moussa Diallo, MD
Towards understanding the molecular and cellular cross-talk in keloid pathophysiology.
Mark Fear, PhD
Insights into keloid pathogenesis arising from a site-specific in situ approach.
Natalie Jumper, MD, PhD
Head and Neck Keloids: Epidemiology and epigenetic signatures.
Lamont Jones, MD, MBA
Network integration of epigenomic data: Leveraging the concept of master regulators to prioritize keloid-specific therapeutic tar-gets.
Maria J. Worsham, PhD
Clinical case presentation
10:30-11:00
Coffee break & exhibition
11:00 - 12:30
Role of Surgery in Treatment of Keloid Lesions
New techniques for keloid surgery.
Mohsen Alirezaii, MD
Surgical management of head and neck keloids.
Lamont Jones, MD, MBA
The role of radiotherapy in the treatment of keloids.
Jonathan Tsao, MD
Shortcomings of surgery in treatment of keloids.
Michael H. Tirgan, MD
Psycho-social impact of keloid disorder.
Lina Ndjock
Clinical case presentation
12:30 - 14:30
Lunch break & exhibition
12:30 - 14:30
Special Session: Industry Lunch Session
14:30 - 16:00
Non-Surgical Treatments of keloid lesions
Phenol and Keloids: Myth or reality?
Said Amal, MD
Role of laser in treatment of keloids: What is new?
Reza Ghohestani, MD, PhD
Injectables, from steroids to chemotherapy drugs.
Michael H. Tirgan, MD
Cryotherapy, when, where, and how to use it?
Michael H. Tirgan, MD
Clinical and Epidemiological experience of keloids in the Depart-ment of Dermatology at Ibn Rochd University Hospital
A. Aboutamm, MD
Genetic Signature of Keloids. Lessons learned from liver fibrosis
Alain Dessin, PhD
Clinical case presentation
16:00 - 16:30
Coffee break, poster viewing & exhibition
16:30: 18:00
Research in keloid disorder
Investigation of the role of epigenetic modification in keloid scar pathology.
Mansour A. Alghamdi, PhD
Keloids and hypertrophic scars: experience of the Department of Dermatology at CHU Hospital Hassan II, Fes.
Fatima Z. Mernissi, MD
Heterogeneity in of keloid pathology. Is it a factor in keloid
recurrence ?
Ferdinand Nangole, MD
Role of mesenchymal stem cells in keloid.
Hesham M. Ahmad, MD
Lessons learned from keloid survey and clinical research.
Michael H. Tirgan, MD
Consensus meeting on clinical management of keloids.
Reza Ghohestani, MD, PhD
18:00 - 19:00
Reception
20:00-23:00
Gala dinner
